Israel’s Chief Scientist on Mastering the Art of Public-Private Partnership | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« 3D Printing Options: Printing 3D plastic structures in macroscopic scale or Printing in DNA at the Nanoscale

Cancer, Respiration and the Peril of the Heart in Cancer Patients »

Israel’s Chief Scientist on Mastering the Art of Public-Private Partnership

August 3, 2015 by 2012pharmaceutical

Israel’s Chief Scientist on Mastering the Art of Public-Private Partnership

Reporter: Aviva Lev-Ari, PhD, RN

Israel’s Chief Scientist on Mastering the Art of Public-Private Partnership.

This article was published by Gil Press in Forbes.

Posted in BioTechnology - Venture Creation, Venture Capital | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,459 other subscribers
Recent Posts
- Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
- The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
- Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
- Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
- Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
- Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
- Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
- Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: